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A 40-year-old man with no known co-morbid it ies
presented with a history of numbness and weakness of
both hands and feet for 3 months, along with difficulty in
walking and left foot drop for 2 weeks. On systemic
inqui ry,  he was found to have low grade fever,
polyarthralgia, skin rash, weight loss and anorexia. He was
married and had four children. He was a salesman by
profession and had been living in the Middle East for the
last 16 years. Sexual history was positive for extramarital
contacts.
On examination, he was a middle-aged cachectic male
with blood pressure of 150/90 mmHg and pulse of 80 per
minute. He was afebr i le. Peripheral cyanosis and
erythematous macular rashes were noted on both lower
extremities. Higher mental functions, cranial nerves, and
cerebellar functions were intact. He had significant
wasting of the small muscles in both hands. Power was
3/5 in intrinsic hand muscles bilaterally, 4+/5 in the rest
of the upper limbs, 1/5 in left ankle dorsiflexion, 3/5 in
right ankle dorsiflexion, and 4+/5 in the rest of the lower
limb musculature. The left ankle deep-tendon reflex was
absent, the right ankle reflex was diminished, and the
other deep-tendon reflexes were normal. Sensory loss in a
glove-and-stocking distribution was detected in all sensory
modalities. He walked with a slapping, high-stepping gait.
Laboratory evaluation showed normocytic normochromic
anemia. ESR was 65 mm. Chest X-Ray and urinalysis were
normal. Alanine transaminase was raised at 46 mg/dl.
Serology was positive for hepatitis B surface antigen but
negative for anti-HCV as well as anti-HIV I and II. Assays
for antinuclear antibodies (ANA) and anti double-stranded
DNA were also negative. Electromyography and nerve
conduction studies showed an asymmetric primarily axonal
sensorimotor polyneuropathy. Sural nerve biopsy revealed
transmural inflammation and necrosis of medium-sized
blood vessels, suggestive of active necrotizing vasculitis
(Figure 1).
A diagnosis of vasculit ic neuropathy secondary to
polyarterit is nodosa in association with hepatitis B
antigaenemia was made. Our patient fulfilled diagnostic
criteria for PAN described by the American college of
Rheumatology in 1990.9
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ABSTRACT
Polyarteritis nodosa (PAN) causes transmural necrotizing inflammation of small- or medium-sized muscular arteries. PAN is
also observed as a complication of hepatitis B, hepatitis C, and HIV infection. Disease manifestations are diverse and
complex; however, peripheral neuropathy is one of the commonest presenting features. We describe a case of vascuilitic
neuropathy in a patient with PAN and discuss the association with hepatitis B infection.
Figure 1. Sural nerve biopsy showing transmural
necrotizing inflammation
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Treatment was begin with intravenous methyl prednisolone
(1 g once daily for 3 days), followed by oral prednisone.
He was also started on oral azathioprine and was referred
to gastroenterology for management of hepatitis B
infection.
DISCUSSION
Vasculitis is inflammation in the vessel wall. The systemic
vasculitides represent a highly heterogeneous group of
clinicopathological entities. Although vasculitis has many
causes, it produces a limited number of histological
patterns of vascular inflammation. Clinical expression
depends on the site, type and size of vessel involved.
Vessels of any type in any organ can be affected, which is
reflected in the diversity of signs and symptoms. 
In terms of clinical course, the systemic vasculitides range
from benign, locally restricted processes (for e.g.,
cutaneous leukocytoclastic angiitis) to systemic vascuilitis
leading to life-threatening conditions, such as pulmonary-
renal syndrome in antineutrophil cytoplasmic antibody
(ANCA)-associated vasculitis.1
Polyarteritis nodosa or periarteritis nodosa was first
described by Kussmaul and Maier in 1866. A focal
segmental necrotizing vasculitis of small- and medium-
sized arteries, it affects in order of decreasing frequency
the peripheral nerves, muscles, joints, skin, kidney,
gastrointestinal tract, heart and eyes, and manifests itself
by weight loss, fever, asthenia, hypertension, and
bio logical signs of  inflammation such as anemia,
leukocytosis, thrombocytosis, and increased ESR.2,3
In patients with systemic necrotizing vasculitis, peripheral
neuropathy has been well been documented.4 , 5 A
mononeuropathy or mononeuropathy multiplex as a
characteristic feature of ischemic nerve damage has been
reported in the ear l iest papers.4 More extens ive
neuropathy and symmetric polyneuropathy have also been
emphasized.5 A detailed history, physical examination and
focused laboratory investigations are vital in diagnosing
vasculitic disorders. Laboratory assessment for ANCA,
ANA, complement, cryoglobulins, fecal blood, antibodies
to hepatit is B and C, rheumatoid factor, azotemia,
hematuria and proteinuria is helpful.6
Sergent et al presented substantial evidence which
indicated that at least one subset of PAN patients
experienced systemic vasculitis as a result of hepatitis B
virus-associated immune complex disease.7 Guillevin et al
in France in a 1981-1992 study also reported that 25-
30% of PAN patients are associated with hepatitis B,
based on HBsAg positivity.8 In 1990, the American
College of  Rheumatology proposed a set o f PAN
classification criteria, which included the presence of
HBsAg or HBsAb in serum as part of the criteria.9
The definitive diagnosis of systemic vasculitis, however, is
dependent on the demonstration of vascular involvement
by either biopsy or angiography. Biopsy specimens should
be obtained only from clinically involved accessible
tissue.1
Prednisolone-based treatment is well known in PAN.
Sometimes a cytotoxic agent and plasmaphresis are
added.8 Treatment of underlying Hepatitis B infection has
also been shown to cure the disease.10
CONCLUSION
Polyarteritis nodosa is a recognized systemic complication
of hepatitis B infection and patients can have serious
extrahepat ic manifestat ions even wi th minimal to
moderate hepatic invo lvement. Nerve b iopsy is an
important diagnostic tool in confirmation of vasculitic
neuropathy.
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